CY1107358T1 - Μεθοδος για τη διαγνωση της ιδιοπαθους σκολιωσης εφηβων και σχετικων συνδρομων - Google Patents
Μεθοδος για τη διαγνωση της ιδιοπαθους σκολιωσης εφηβων και σχετικων συνδρομωνInfo
- Publication number
- CY1107358T1 CY1107358T1 CY20081100337T CY081100337T CY1107358T1 CY 1107358 T1 CY1107358 T1 CY 1107358T1 CY 20081100337 T CY20081100337 T CY 20081100337T CY 081100337 T CY081100337 T CY 081100337T CY 1107358 T1 CY1107358 T1 CY 1107358T1
- Authority
- CY
- Cyprus
- Prior art keywords
- cell sample
- melatonin
- signaling pathway
- adolescents
- diagnosis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Testing Of Engines (AREA)
- Saccharide Compounds (AREA)
Abstract
Μέθοδος για τη διάγνωση υψηλού κινδύνου για πάθηση χαρακτηριζόμενη από δυσλειτουργική πορεία σηματοδότησης μελατονίνης σε ζώο, περιλαμβάνουσα την ανίχνευση της παρουσίας ή απουσίας τουλάχιστον μίας βλάβης στην πορεία σηματοδότησης μελατονίνης σε τουλάχιστον ένα από τα κύτταρα του ζώου, όπου η παρουσία τουλάχιστον μίας βλάβης στην πορεία σηματοδότησης μελατονίνης δείχνει ότι το ζώο εμφανίζει υψηλό κίνδυνο ανάπτυξης της εν λόγω πάθησης, και μέθοδος για την εξέταση ως προς ένωση χρήσιμη στην αντιμετώπιση παθήσεων χαρακτηριζόμενων από δυσλειτουργική πορεία σηματοδότησης μελατονίνης, η οποία μέθοδος περιλαμβάνει τα στάδια της επαφής μίας υποψήφιας ένωσης με τουλάχιστον ένα κύτταρο που εκφράζει τουλάχιστον μία βλάβη στην πορεία σηματοδότησης μελατονίνης, όπου η υποψήφια ένωση επιλέγεται εάν η εν λόγω βλάβη στην πορεία σηματοδότησης μελατονίνης περιορίζεται με την παρουσία της υποψήφιας ένωσης σε σύγκριση με τη βλάβη χωρίς την παρουσία αυτής.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002373854A CA2373854A1 (en) | 2002-02-28 | 2002-02-28 | Methods of diagnosing and counteracting adolescent idiopathic scoliosis |
EP03706157A EP1478928B1 (en) | 2002-02-28 | 2003-02-28 | Method of diagnosing adolescent idiopathic scoliosis and related syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107358T1 true CY1107358T1 (el) | 2012-12-19 |
Family
ID=27762090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20081100337T CY1107358T1 (el) | 2002-02-28 | 2008-03-24 | Μεθοδος για τη διαγνωση της ιδιοπαθους σκολιωσης εφηβων και σχετικων συνδρομων |
Country Status (12)
Country | Link |
---|---|
US (7) | US20050130250A1 (el) |
EP (1) | EP1478928B1 (el) |
AT (1) | ATE385574T1 (el) |
AU (1) | AU2003208204A1 (el) |
CA (1) | CA2373854A1 (el) |
CY (1) | CY1107358T1 (el) |
DE (1) | DE60318987T2 (el) |
DK (1) | DK1478928T3 (el) |
ES (1) | ES2298498T3 (el) |
HK (1) | HK1071601A1 (el) |
PT (1) | PT1478928E (el) |
WO (1) | WO2003073102A1 (el) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2373854A1 (en) | 2002-02-28 | 2003-08-28 | Alain Moreau | Methods of diagnosing and counteracting adolescent idiopathic scoliosis |
US20090104620A1 (en) * | 2007-07-03 | 2009-04-23 | Axial Biotech, Inc. | Simplified Method of Determining Predisposition to Scoliosis |
US20090035769A1 (en) * | 2007-12-31 | 2009-02-05 | Nelson Lesa M | Genetic Markers Associated with Scoliosis and Uses Thereof |
US20090035772A1 (en) * | 2007-07-03 | 2009-02-05 | Axial Biotech, Inc. | Genetic Markers Associated With Scoliosis And Uses Thereof |
US7655403B2 (en) * | 2006-12-02 | 2010-02-02 | Texas Scottish Rite Hospital For Children | CHD7 gene polymorphisms are associated with susceptibility to idiopathic scoliosis |
US20100173296A1 (en) * | 2007-03-19 | 2010-07-08 | Chu Sainte-Justine | Methods of stratifying adolescent idiopathic scoliosis, isolated nucleic acid molecules for use in same and kits using same |
KR101436578B1 (ko) | 2007-03-30 | 2014-09-01 | 슈 생-쥐스땡 | 척추 측만증의 발병 위험성을 측정하는 방법, 척추 측만증에 걸린 대상자를 계층화하는 방법, 척추 측만증에 걸린 대상자에 있어서 고정기의 효능을 평가하는 방법, 및 이를 위한 키트 |
TWI443337B (zh) * | 2008-10-10 | 2014-07-01 | Ct Hospitalier Universitaire Sainte Justine | 用於脊柱側彎之分類及診斷的方法 |
WO2012045176A1 (en) | 2010-10-04 | 2012-04-12 | Chu Sainte-Justine | Biomechanical-based methods of diagnosing scoliosis |
AU2014284079B2 (en) | 2013-06-17 | 2019-05-23 | Chu Sainte-Justine | A method of increasing GiPCR signalization in the cells of a scoliotic subject |
EP3011332B1 (en) | 2013-06-17 | 2019-09-18 | CHU Sainte-Justine | New markers for severe progression of idiopathic scoliosis and uses thereof to stratify scoliotic patients and predict the risk of developing scoliosis |
US20160139146A1 (en) | 2013-06-17 | 2016-05-19 | Chu Sainte-Justine | Gi protein phosphorylation as marker for scoliosis and scoliosis progression, methods of increasing gipcr signaling in scoliotic subjects |
EP3044321B1 (en) * | 2013-09-09 | 2019-07-31 | Chu Sainte-Justine | New marker for the classification, diagnosis and treatment of scoliosis |
KR102397233B1 (ko) | 2014-09-25 | 2022-05-12 | 프로제너티, 인크. | 위치추정 능력을 갖는 전기기계 알약 장치 |
ES2734803T3 (es) * | 2015-06-16 | 2019-12-12 | Centro De Investig Biomedica En Red Ciber | Método para el diagnóstico/pronóstico de la escoliosis idiopática del adolescente |
JP7153633B2 (ja) * | 2016-08-18 | 2022-10-14 | ビオラ・セラピューティクス・インコーポレイテッド | サンプリングシステム、ならびに関連する材料および方法 |
JP2019526423A (ja) | 2016-09-09 | 2019-09-19 | ミッチェル・ローレンス・ジョーンズMitchell Lawrence JONES | 分注可能物質の送達のための電気機械的摂取可能装置 |
EP4252629A3 (en) | 2016-12-07 | 2023-12-27 | Biora Therapeutics, Inc. | Gastrointestinal tract detection methods, devices and systems |
JP7071995B2 (ja) | 2017-03-31 | 2022-05-19 | プロジェニティ, インコーポレイテッド | 摂取可能装置 |
KR20210095165A (ko) | 2018-11-19 | 2021-07-30 | 프로제너티, 인크. | 바이오의약품으로 질환을 치료하기 위한 방법 및 디바이스 |
CN111575361A (zh) * | 2020-04-20 | 2020-08-25 | 孙欣 | 一种褪黑素通路调控因子治疗ais患者的测试方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5856124A (en) * | 1994-06-17 | 1999-01-05 | The General Hospital Corporation | DNA encoding high-affinity melatonin receptors |
US5889177A (en) * | 1996-07-18 | 1999-03-30 | The General Hospital Corporation | Melatonin 1A receptor gene regulatory regions and uses thereof |
JPH119282A (ja) * | 1997-06-19 | 1999-01-19 | Nippon Chem Res Kk | メラトニン受容体発現細胞とその用途 |
WO2001009383A2 (en) * | 1999-07-30 | 2001-02-08 | Millennium Pharmaceuticals, Inc. | Compositions, kits, and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disorders |
CA2373854A1 (en) | 2002-02-28 | 2003-08-28 | Alain Moreau | Methods of diagnosing and counteracting adolescent idiopathic scoliosis |
-
2002
- 2002-02-28 CA CA002373854A patent/CA2373854A1/en not_active Abandoned
-
2003
- 2003-02-28 EP EP03706157A patent/EP1478928B1/en not_active Expired - Lifetime
- 2003-02-28 AT AT03706157T patent/ATE385574T1/de not_active IP Right Cessation
- 2003-02-28 ES ES03706157T patent/ES2298498T3/es not_active Expired - Lifetime
- 2003-02-28 DK DK03706157T patent/DK1478928T3/da active
- 2003-02-28 AU AU2003208204A patent/AU2003208204A1/en not_active Abandoned
- 2003-02-28 WO PCT/CA2003/000286 patent/WO2003073102A1/en active IP Right Grant
- 2003-02-28 DE DE60318987T patent/DE60318987T2/de not_active Expired - Lifetime
- 2003-02-28 PT PT03706157T patent/PT1478928E/pt unknown
- 2003-02-28 US US10/505,951 patent/US20050130250A1/en not_active Abandoned
-
2005
- 2005-05-18 HK HK05104180A patent/HK1071601A1/xx not_active IP Right Cessation
-
2008
- 2008-03-24 CY CY20081100337T patent/CY1107358T1/el unknown
- 2008-09-11 US US12/232,141 patent/US7989175B2/en not_active Expired - Fee Related
-
2011
- 2011-06-21 US US13/165,226 patent/US20110256582A1/en not_active Abandoned
- 2011-06-21 US US13/165,404 patent/US20120009600A1/en not_active Abandoned
-
2012
- 2012-12-24 US US13/726,416 patent/US8652791B2/en not_active Expired - Fee Related
-
2013
- 2013-12-30 US US14/143,811 patent/US20140113313A1/en not_active Abandoned
-
2016
- 2016-05-19 US US15/159,222 patent/US20160258947A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20110256582A1 (en) | 2011-10-20 |
DE60318987T2 (de) | 2009-01-29 |
US20120009600A1 (en) | 2012-01-12 |
ES2298498T3 (es) | 2008-05-16 |
DK1478928T3 (da) | 2008-05-19 |
US20160258947A1 (en) | 2016-09-08 |
DE60318987D1 (de) | 2008-03-20 |
EP1478928A1 (en) | 2004-11-24 |
PT1478928E (pt) | 2008-04-09 |
HK1071601A1 (en) | 2005-07-22 |
EP1478928B1 (en) | 2008-02-06 |
US20130115615A1 (en) | 2013-05-09 |
ATE385574T1 (de) | 2008-02-15 |
US7989175B2 (en) | 2011-08-02 |
US20140113313A1 (en) | 2014-04-24 |
WO2003073102A1 (en) | 2003-09-04 |
US8652791B2 (en) | 2014-02-18 |
US20050130250A1 (en) | 2005-06-16 |
AU2003208204A1 (en) | 2003-09-09 |
US20090111110A1 (en) | 2009-04-30 |
CA2373854A1 (en) | 2003-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107358T1 (el) | Μεθοδος για τη διαγνωση της ιδιοπαθους σκολιωσης εφηβων και σχετικων συνδρομων | |
ATE330038T1 (de) | Nukleinsäure-biosensor | |
DE69938662D1 (de) | Spurendetektion von analyten mit hilfe artifizieller olfaktometrie | |
DE60228557D1 (de) | Candida-nachweis | |
DK1766400T3 (da) | Fremgangsmåde til at udföre fuldblodsanalyser | |
EP2520935A3 (en) | Organ-specific proteins and methods of their use | |
EP1318399A3 (en) | Passive sample detection to initiate timing of an assay | |
NO20072721L (no) | Polypeptides that bind BR3 and uses thereof | |
EA200600452A1 (ru) | Автоматизированные способы и системы для обнаружения и анализа сосудистых бляшек | |
DE60325180D1 (de) | Mikrovorrichtungen zur untersuchung von biologischen systemen | |
EP2472258A3 (en) | Highly sensitive system and methods for analysis of troponin | |
EP2287618A3 (en) | Method for diagnosing neuro-degenerative disease | |
ITRM20030386A0 (it) | Metodo e test diagnostici basati sull'analisi citofluorimetrica dei linfociti t antigene-specifici. | |
NO20052992L (no) | Markorproteiner for diagnostisering av leversykdom og fremgangsmate for diagnostisering av leversykdom. | |
WO2002093129A3 (en) | Methods for analyzing interactions between proteins in live and intact cells | |
FR2886006B1 (fr) | Procede et appareil pour la determination d'un allongement, et capteur d'extensometrie mis en oeuvre pour ce procede | |
WO2004057341A3 (en) | Cvd assay | |
ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
WO2002012892A3 (en) | Rapid multiple panel of biomarkers in laboratory blood tests for tia/stroke | |
DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
DK1051491T3 (da) | Equin Fc Epsilon receptor-alfa-kæde-nukleinsyremolekyler, korresponderende proteiner og anvendelse heraf | |
DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
EP2508886A3 (en) | Means and methods for classifying samples of multiple sclerosis patients | |
DK2095126T3 (da) | Fremgangsmåde til påvisning af humant parvovirusantigen |